Participating Faculty: Management of Advanced/Metastatic Melanoma: New and Emerging Treatment Pathways, Therapies, and Challenges [CPE]

Faculty

This supplement to The American Journal of Managed Care is intended to provide an understanding of the epidemiology of advanced and metastatic melanoma, the known pathways involved in the pathophysiology of melanoma, and the approved and emerging therapies that target these pathways. It will also focus on the most recent clinical data from immunotherapy trials, therapies formulated to target metastatic melanoma and their corresponding outcomes, adverse effects, and costs associated with the use of these pharmacologic agents.

Daniel A. Goldstein, MD

Fellow in Hematology and Medical Oncology

Winship Cancer Institute of Emory University

Atlanta, Georgia

Trevor McKibbin, PharmD, MS, BCOP

Clinical Pharmacy Specialist: Hematology/Medical Oncology

Winship Cancer Institute of Emory University

Adjunct Assistant Professor

Department of Hematology and Medical Oncology

Emory University School of Medicine

Atlanta, Georgia

Simon B. Zeichner, DO

Hematology/Oncology fellow, PGY-5

Winship Cancer Institute of Emory University

Atlanta, Georgia

Editorial Support

Anna Azvolinsky, PhD

Freelance Science and Health Journalist

New York, New York

Priya Karkhanis

Scientific Consultant

Hillsborough, New Jersey

Yvette C. Terrie, RPh

Clinical Pharmacist/Consultant Pharmacist

Haymarket, Virginia

Faculty Disclosures

Daniel A. Goldstein, MD; Trevor McKibbin, PharmD, MS, BCOP; and Simon B. Zeichner, DO, have no relevant commercial financial relationships or affiliations to disclose.

Editorial Support Disclosures

Anna Azvolinsky, PhD; Priya Karkhanis; and Yvette C. Terrie, RPh, have no relevant commercial financial relationships or affiliations to disclose.

The American Journal of Managed Care

Publishing Staff—Jeff D. Prescott, PharmD, RPh; Ida Delmendo; and Cindy Spielvogel have no relevant financial relationships with commercial interests to disclose.

Pharmacy Times Office of Continuing Professional Education

Planning staff— David Heckard; Maryjo Dixon, RPh; Dipti Desai, PharmD, RPh; Donna Fausak; and Nathalie Harden have no relevant financial relationships with commercial interests to disclose.

Disclosure Policy

According to the disclosure policy of The American Journal of Managed Care, all persons who are in a position to control content are required to disclose any relevant financial relationships with commercial interests. If a conflict is identified, it is the responsibility of the American Journal of Managed Care and Pharmacy Times Office of Continuing Professional Education to initiate a mechanism to resolve the conflict(s). The existence of these relationships is not viewed as implying bias or decreasing the value of the activity. All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

Disclosure of Unapproved/Off-Label Use

The contents of this activity may include information regarding the use of products that may be inconsistent with or outside the approved labeling for these products in the United States. Participants should note that the use of these products outside current approved labeling is considered experimental and are advised to consult prescribing information for these products.

The information provided in this CE activity is for continuing medical and pharmacy education purposes only and is not meant as a substitute for the independent medical or pharmacy judgment of a physician or pharmacist relative to diagnostic, treatment, or management options for a specific patient’s medical condition.

The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of The American Journal of Managed Care, Pharmacy Times Office of Continuing Professional Education, or any of the companies that provided commercial support for this CE activity.

Signed disclosures are on file at the office of The American Journal of Managed Care, Plainsboro, New Jersey.

Opinions expressed by authors, contributors, and advertisers are their own and not necessarily those of Clinical Care Targeted Communications, LLC, d/b/a Managed Care & Healthcare Communications, LLC, the editorial staff, or any member of the editorial advisory board. Clinical Care Targeted Communications, LLC, d/b/a Managed Care & Healthcare Communications, LLC, is not responsible for accuracy of dosages given in articles printed herein. The appearance of advertisements in this publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality, or safety. Clinical Care Targeted Communications, LLC, d/b/a Managed Care & Healthcare Communications, LLC, disclaims responsibility for any injury to persons or property resulting from any ideas or products referred to in the articles or advertisements.

Download PDF: Participating Faculty: Management of Advanced/Metastatic Melanoma: New and Emerging Treatment Pathways, Therapies, and Challenges [CPE]